Cytokines and chemokines in allergic bronchopulmonary aspergillosis (ABPA) and experimental aspergillus-induced allergic airway or asthmatic disease

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Hogaboam, Cory M ^a   Blease, Kate ^a   Schuh, Jane M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Cytokines; Review; Th1; Th2; Therapy

Indexed keywords

CHEMOKINE; COSALANE; CYTOKINE; RANTES;

ALLERGY; ASPERGILLUS FUMIGATUS; ASTHMA; CELLULAR IMMUNITY; HUMAN; IMMUNOMODULATION; LUNG ASPERGILLOSIS; PROTEIN TARGETING; REVIEW; TH1 CELL; TH2 CELL;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; MURINAE;

EID: 3142675842     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Denning D. W.: Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 7 Suppl 2, 25-31 (2001)
2. Sharma O. P., R. Chwogule: Many faces of pulmonary aspergillosis. Eur Respir J 12, 705-715 (1998)
3. Franquet T., N. L. Muller, A. Gimenez, P. Guembe, J. de La Torre, S. Bague: Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 21, 825-837 (2001)
4. Daly P., K. Kavanagh: Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci 58, 197-205 (2001)
5. Kurup V. P., H. Choi, P. S. Murali, R. L. Coffman: IgE and eosinophil regulation in a murine model of allergic aspergillosis. J Leukoc Biol 56, 593-598 (1994)
6. Hogaboam C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, N. W. Lukacs: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156, 723-732 (2000)
7. Hanley-Lopez J., L. T. Clement: Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med 6, 540-544 (2000)
8. Wark P. A., P. G. Gibson: Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 6, 1-7 (2001)
9. Kauffman H. F., J. F. Tomee, T. S. van der Werf, J. G. de Monchy, G. K. Koeter: Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 151, 2109-2115; discussion 2116 (1995)
10. Vlahakis N. E., T. R. Aksamit: Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 76, 930-938 (2001)
11. Taub D. D.: Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 7, 355-376 (1996)
12. Kelner G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Lagaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, A. Zlotnik: Lymphotactin: a cytokine that represents a new class of chemokine. Science 266, 1395. (1994)
13. Pan Y., C. Lloyd, H. Zhou, S. Dolich, J. Deeds, J. A. Gonzalo, J. Vath, M. Gosselin, J. Ma, B. Dussault, E. Woolf, G. Alperin, J. Culpepper, J. C. Gutierrez-Ramos, D. Gearing: Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387, 611-617. (1997)
14. Zlotnik A., O. Yoshie: Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127 (2000)
15. Premack B. A., T. J. Schall: Chemokine receptors: gateways to inflammation and infection. Nature Med. 2, 1174-1178. (1996)
16. Frade J. M., M. Mellado, G. del Real, J. C. Gutierrez-Ramos, P. Lind, A. C. Martinez: Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol 159, 5576-5584 (1997)
17. Raport C. J., J. Gosling, V. L. Schweickart, P. W. Gray, I. F. Charo: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 271, 17161-17166 (1996)
18. Mosmann T. R., H. Cherwinski, e. a. M.W. Bond MW: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136, 2348-2357 (1986)
19. Plaut M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, W. E. Paul: Mast cell lines produce lymphokines in response to crosslinking FcER1 or to calcium ionophores. Nature 339, 64 (1989)
20. McKenzie G. J., A. Bancroft, R. K. Grencis, A. N. McKenzie: A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr Biol 8, 339-342 (1998)
21. Finkelman F. D., J. F. Urban, Jr.: The other side of the coin: the protective role of the TH2 cytokines. J Allergy Clin Immunol 107, 772-780. (2001)
22. Mosmann T. R., K. W. Moore: The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol Today 12, 49-53. (1991)
23. Tomee J. F., A. T. Wierenga, P. S. Hiemstra, H. K. Kauffman: Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 176, 300-303 (1997)
24. Borger P., G. H. Koeter, J. A. Timmerman, E. Vellenga, J. F. Tomee, H. F. Kauffman: Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis 180, 1267-1274 (1999)
25. Kauffman H. F., J. F. Tomee, M. A. van de Riet, A. J. Timmerman, P. Borger: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105, 1185-1193 (2000)
26. Blease K., S. L. Kunkel, C. M. Hogaboam: IL-18 modulates chronic fungal asthma in a murine model; putative involvement of Toll-like receptor-2. Inflamm Res 50, 552-560 (2001)
27. Schuyler M.: The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 131, 194-196 (1998)
28. Knutsen A. P., K. R. Mueller, A. D. Levine, B. Chouhan, P. S. Hutcheson, R. G. Slavin: Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 94, 215-221 (1994)
29. Walker C., W. Bauer, R. K. Braun, G. Menz, P. Braun, F. Schwarz, T. T. Hansel, B. Villiger: Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 150, 1038-1048 (1994)
30. Skov M., L. K. Poulsen, C. Koch: Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 27, 74-79 (1999)
31. Rathore V. B., B. Johnson, J. N. Fink, K. J. Kelly, P. A. Greenberger, V. P. Kurup: T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. Clin Immunol 100, 228-235 (2001)
32. Khan S., J. S. McClellan, A. P. Knutsen: Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 123, 319-326 (2000)
33. Latge J. P.: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12, 310-350 (1999)
34. Mehrad B., R. M. Strieter, T. J. Standiford: Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J Immunol 162, 1633-1640 (1999)
35. Hogaboam C. M., C. S. Gallinat, D. D. Taub, R. M. Strieter, S. L. Kunkel, N. W. Lukacs: Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J Immunol 162, 6071-6079 (1999)
36. Grunig G., D. B. Corry, M. W. Leach, B. W. Seymour, V. P. Kurup, D. M. Rennick: Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185, 1089-1099 (1997)
37. Roilides E., A. Dimitriadou, I. Kadiltsoglou, T. Sein, J. Karpouzas, P. A. Pizzo, T. J. Walsh: IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol. 158, 322-329 (1997)
38. Corry D. B., G. Grunig, H. Hadeiba, V. P. Kurup, M. L. Warnock, D. Sheppard, D. M. Rennick, R. M. Locksley: Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4, 344-355 (1998)
39. Kurup V. P., J. Q. Xia, D. A. Rickaby, C. A. Dawson, H. Choi, J. N. Fink: Aspergillus fumigatus antigen exposure results in pulmonary airway resistance in wild-type but not in IL-4 knockout mice. Clin Immunol 90, 404-410 (1999)
40. Blease K., C. Jakubzick, J. Westwick, N. Lukacs, S. L. Kunkel, C. M. Hogaboam: Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 166, 5219-5224 (2001)
41. Kurup V. P., H. Y. Choi, P. S. Murali, J. Q. Xia, R. L. Coffman, J. N. Fink: Immune responses to Aspergillus antigen in IL-4-/-mice and the effect of eosinophil ablation. Allergy 54, 420-427 (1999)
42. Murali P. S., A. Kumar, H. Choi, N. K. Banasal, J. N. Fink, V. P. Kurup: Aspergillus fumigatus antigen induced eosinophilia in mice is abrogated by anti-IL-5 antibody. J Leukoc Biol 53, 264-267 (1993)
43. Kurup V. P., P. S. Murali, J. Guo, H. Choi, B. Banerjee, J. N. Fink, R. L. Coffman: Anti-interleukin (IL)-4 and -IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52, 1215-1221 (1997)
44. Blease K., C. Jakubzick, J. M. Schuh, B. H. Joshi, R. K. Puri, C. M. Hogaboam: IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice. J Immunol 167, 6583-6592 (2001)
45. Blease K., J. Schuh, C. Jakubzick, N. W. Lukacs, S. L. Kunkel, B. H. Joshi, R. K. Puri, M. H. Kaplan, C. M. Hogaboam: Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol in press., (2001)
46. Kurup V. P., J. Guo, P. S. Murali, H. Choi, J. N. Fink: Immunopathologic responses to Aspergillus antigen in interleukin-4 knockout mice. J Lab Clin Med 130, 567-575 (1997)
47. Schuh J. M., K. Blease, S. L. Kunkel, C. M. Hogaboam: Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus. Am J Physiol Lung Cell Mol Physiol in press, (2002)
48. Zimmermann N., S. P. Hogan, A. Mishra, E. B. Brandt, T. R. Bodette, S. M. Pope, F. D. Finkelman, M. E. Rothenberg: Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 165, 5839-5846 (2000)
49. Hogaboam C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, N. W. Lukacs: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 156, 723-732. (2000)
50. Blease K., B. Mehrad, T. J. Standiford, N. W. Lukacs, S. L. Kunkel, S. W. Chensue, B. Lu, C. J. Gerard, C. M. Hogaboam: Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol 165, 1564-1572 (2000)
51. Blease K., B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, C. M. Hogaboam: Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice. J Immunol 165, 2603-2611 (2000)
52. Schuh J. M., K. Blease, C. M. Hogaboam: CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 168, 1447-1456 (2002)
53. Schuh J. M., K. Blease, C. M. Hogaboam: The role of CC chemokine receptor 5 (CCR5) and RANTES/CCL5 during chronic fungal asthma in micel. Faseb J, (2001)
54. Blease K., B. Mehrad, N. W. Lukacs, S. L. Kunkel, T. J. Standiford, C. M. Hogaboam: Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia. J Immunol 166, 1832-1842. (2001)
55. Judson M. A., D. A. Stevens: Current pharmacotherapy of allergic bronchopulmonary aspergillosis. Expert Opin Pharmacother 2, 1065-1071 (2001)
56. Stevens D. A., H. J. Schwartz, J. Y. Lee, B. L. Moskovitz, D. C. Jerome, A. Catanzaro, D. M. Bamberger, A. J. Weinmann, C. U. Tuazon, M. A. Judson, T. A. Platts-Mills, A. C. DeGraff, Jr.: A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 342, 756-762 (2000)
57. Stevens D. A., B. J. Kullberg, E. Brummer, A. Casadevall, M. G. Netea, A. M. Sugar: Combined treatment: antifungal drugs with antibodies, cytokines or drugs. Med Mycol 38 Suppl 1, 305-315 (2000)
58. Bianchi G., S. Sozzani, A. Zlotnick, A. Mantovani, P. Allavena: Migratory response of human NK cells to lymphotactin. Eur. J. Immunol. 26, 3238. (1996)
59. Wells T. N., A. E. Proudfoot: Chemokine receptors and their antagonists in allergic lung disease. Inflamm Res 48, 353-362 (1999)
60. Proudfoot A. E., T. N. Wells, P. R. Clapham: Chemokine receptors - future therapeutic targets for HIV? Biochem Pharmacol 57, 451-463 (1999)
61. Takeda K., S. Akira: STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev 11, 199-207 (2000)
62. Zhang S., N. W. Lukacs, V. A. Lawless, S. L. Kunkel, M. H. Kaplan: Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J Immunol 165, 10-14 (2000)
63. Lawless V. A., S. Zhang, O. N. Ozes, H. A. Bruns, I. Oldham, T. Hoey, M. J. Grusby, M. H. Kaplan: Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol 165, 6803-6808 (2000)
64. Takeda K., T. Kishimoto, S. Akira: STAT6: its role in interleukin 4-mediated biological functions. J Mol Med 75, 317-326 (1997)
65. Prieto J., C. Lensmar, A. Roquet, I. van der Ploeg, D. Gigliotti, A. Eklund, J. Grunewald: Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 94, 806-814 (2000)
66. Huang S. K., H. Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, M. C. Liu: IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155, 2688-2694 (1995)
67. Grunig G., M. Warnock, A. E. Wakil, R. Venkayya, F. Brombacher, D. M. Rennick, D. Sheppard, M. Mohrs, D. D. Donaldson, R. M. Locksley, D. B. Corry: Requirement for IL-13 independently of IL-4 in experimental asthma [see comments]. Science 282, 2261-2263 (1998)
68. Wills-Karp M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, D. D. Donaldson: Interleukin-13: central mediator of allergic asthma [see comments]. Science 282, 2258-2261 (1998)
69. Hilton D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, T. A. Willson: Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93, 497-501 (1996)
70. Murata T., J. Taguchi, R. K. Puri, H. Mohri: Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system. Int J Hematol 69, 13-20 (1999)
71. Donaldson D. D., M. J. Whitters, L. J. Fitz, T. Y. Neben, H. Finnerty, S. L. Henderson, R. M. O'Hara, Jr., D. R. Beier, K. J. Turner, C. R. Wood, M. Collins: The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 161, 2317-2324 (1998)
72. Brombacher F.: The role of interleukin-13 in infectious diseases and allergy. Bioessays 22, 646-656 (2000)
73. Zhu Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, J. A. Elias: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103, 779-788 (1999)
74. Corry D. B.: IL-13 in allergy: home at last. Curr Opin Immunol 11, 610-614 (1999)
75. Webb D. C., A. N. McKenzie, A. M. Koskinen, M. Yang, J. Mattes, P. S. Foster: Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 165, 108-113 (2000)
76. Husain S. R., B. H. Joshi, R. K. Puri: IL-13 receptor directed therapy of human malignant glioma in xenograft model. Int. J. Cancer 92, 168-175 (2001)
77. Kawakami K., M. Kawakami, B. H. Joshi, R. K. Puri: Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer. Cancer Res 61, 6194-6200 (2001)
78. Kawakami K., B. H. Joshi, R. K. Puri: Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain. Hum Gene Ther 11, 1829-1835. (2000)
79. Cocchi F., A. L. DeVico, G.-D. A., S. K. Arya, R. C. Gallo, P. Lusso: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+T cells. Science 270, 1811-1815. (1995)
80. Howard O. M., H. F. Dong, J. J. Oppenheim, S. Insaf, K. C. Santhosh, G. Paul, M. Cushman: Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds. Bioorg Med Chem Lett 11, 59-62. (2001)